Skip to main content
Equibles
ALEC logo

ALEC · Alector, Inc. · Metrics

Track ALEC — free

Use ALEC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALEC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.20 +0.10 (+4.76%) Q2 2025 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$251.23M
Shares
111.66M
Volume · Oct 28 1.9M Avg daily vol (3M) 3.26M

ALEC metrics

83 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.25
Market cap
$251.23M

Price action

20 metrics
Price change (1W)
+6.6%
Price change (30D)
+9.4%
Price change (3M)
+38.2%
Price change (6M)
-12.1%
Price change (YTD)
+34.6%
Price change (1Y)
+40.0%
Trailing year
Price change (5Y)
-90.3%
52-week high
$2.72
52-week low
$1.14
Change from 52-week high
-22.8%
Change from 52-week low
+84.2%
Annualized volatility
82.6%
Annualized volatility (3M)
104.4%
Beta
1.6
RSI (14D)
57.3
Price vs SMA 50
+0.6%
Price vs SMA 200
+3.7%
Avg volume (3M)
3.24M
Relative volume
1.4
Average dollar volume
$6.49M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
111.66M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
5.2×
reciprocal yield 19.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
16.9×
reciprocal yield 5.9%
P / book
—
FCF yield
-67.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-50.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
-0.7×
EV / revenue historical average (5Y)
-0.7×
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-13

Profitability

9 metrics
Gross margin
—
Operating margin
-912.4%
Trailing 12 months
Net margin
-850.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$126.49M
Net income (TTM)
−$117.85M
Trailing 12 months
Diluted EPS (TTM)
$-1.10
FCF margin
-1,142.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.13
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.17
EBITDA per diluted share (TTM)
$-1.13
Net income per diluted share (TTM)
$-1.09
Operating cash flow per diluted share (TTM)
$-1.46
Free cash flow per diluted share (TTM)
$-1.46
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.92
Stock compensation per diluted share (TTM)
$0.16
Book value per share
$0.28

Growth

11 metrics
Revenue growth YoY
-57.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$13.86M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+10.8%
Year over year · more shares
Revenue CAGR (3Y)
-46.0%
Revenue CAGR (5Y)
-0.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-58.1%
Debt / equity
—
Current ratio
5.3
EBITDA (TTM)
−$121.95M
Free cash flow (TTM)
−$158.39M
Quick ratio
5.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$162.95M
Latest balance sheet
Cash & equivalents
$59.91M
Total assets
$202.85M
Total debt
$9.85M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$158.23M
Capital expenditures (TTM)
$160,000
R&D (TTM)
$99.13M
SG&A (TTM)
—
Stock compensation (TTM)
$16.76M
R&D / revenue
715.1%
Stock compensation / revenue
120.9%

Ownership (13F)

9 metrics
13F filers
141
13F filer change QoQ
+3
Institutional ownership
82.5%
Conviction holders (share of 13F filers)
2.1%
Crowding (high-turnover and private-fund holders)
39.7%
Private-fund adviser ownership
36.6%
Active holders' share change QoQ
+3.6%
Holder tenure
10.2
Price vs estimated holder cost
-17.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.1%

Short interest

3 metrics
Short interest
9.2%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$296,087
Insider-sentiment score
26 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1653087 CUSIP 014442107 13F (30d) 17 filings 15 filers Visit website Investor relations